NEW YORK, Dec. 13 - Exelixis and Bristol-Myers Squibb said they have identified and selected the first small molecule cancer targets to result from a broad oncology collaboration announced five months ago.

Exelixis, which uses invertebrate and vertebrate gene knockout models to study how certain genes interact in cancer cells to identify particular genes that help suppress tumor growth, said it had identified ways that tumor cells “evade normal growth control mechanisms.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.